Calico

Biology research and drug development targeting aging and age-related diseases for patients and clinical partners

+ Add to sales board

Highlights

  • New on EvolcAdded 2026-11-16

Recent signals

What changed at Calico in the last 6 months, newest first. Each line links to its public source.

  • 15 Oct 2026 Leadership hire · Hiring Associate Director/Director, Biostatistics (South San Francisco) calicolabs.com
  • 9 Oct 2026 Leadership hire · Hiring Head of Medical Affairs (South San Francisco) calicolabs.com

Get signals like these for the companies you sell to →

About Calico

Calico studies the biology of aging and combines basic research, computational biology, machine learning and drug development to advance potential medicines for age-related diseases.

It conducts translational research across areas including neuroscience, oncology, immunology and aging, and develops clinical- and early-stage programs independently and with industry partners. Its programs include candidates for Vanishing White Matter disease, autosomal dominant polycystic kidney disease and oncology.

Founded in 2013 with support from Google, Calico's own labs became operational in 2015. Its open roles are based in South San Francisco, California.

Product: Aging biology research and discovery and development of potential therapeutics for age-related diseases.

Jobs at Calico

No open positions in Europe right now.

Open roles at Calico in the Americas (7)

United States 7. From Calico's careers page or applicant tracking system; each role links to the employer.

Leadership

More biotech & pharma companies

  • cAMPfield Therapeutics

    Clinical-stage biopharma developing prifemilast, an oral PDE4B inhibitor, for ulcerative colitis and Crohn's disease
    San Diego, United StatesBiotech & pharmaFounded 2026
    Young companyNew on Evolc
  • Capable Labs

    AI-driven therapeutics developer building peptide and RNA drugs, starting with sleep disorder programs
    United StatesBiotech & pharma
    New on Evolc
  • Celcuity

    Develops targeted cancer therapies for patients with cancers involving the PAM pathway
    United StatesBiotech & pharma
    New on Evolc
  • Celea Therapeutics

    Develops investigational therapies for serious respiratory diseases, including idiopathic pulmonary fibrosis
    United StatesBiotech & pharma
    New on Evolc
  • Cellanome

    Live-cell imaging and single-cell transcriptomics platform for biology research labs and biopharma companies
    United StatesBiotech & pharma
    New on Evolc
  • Cellarity

    AI and multi-omics drug discovery of oral medicines that correct dysfunctional cell states in complex diseases
    United StatesBiotech & pharma
    New on Evolc

All biotech & pharma companies →

Website technologies

Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.

Analytics

  • Google Analytics 4High confidence
    First detected
    Last detected
    Last checked
    Detection evidence

Content management

  • WordPressHigh confidence
    First detected
    Last detected
    Last checked
    Detection evidence

Hosting

Privacy & consent

  • CookieYesHigh confidence
    First detected
    Last detected
    Last checked
    Detection evidence

Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.